Dictionary

allow_url_fopen is ENABLED Dictionary Search

lymphocytic leukemia

Synonyms

Noun

1. leukemia

2. leukaemia, leucaemia, cancer of the blood

Usage
AbbVie Inc. (ABBV) Hits New Milestone with Venetoclax on Chronic Lymphocytic Leukemia (CLL) Treatment - Yahoo Finance
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy - PR Newswire
EHA: Adding Pirtobrutinib to Venetoclax-Rituximab Ups PFS in Chronic Lymphocytic Leukemia - HealthDay
Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up - OncLive
MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications - Nature
Pirtobrutinib Earns Positive CHMP Opinion Across All CLL Treatment Lines - CancerNetwork
Experts Weigh Fixed-Duration Approaches in Frontline CLL - Targeted Oncology
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia - The New England Journal of Medicine
EHA2026 | Congress coverage: Chronic lymphocytic leukemia and small lymphocytic lymphoma - Lymphoma Hub
Innovative therapies shape the future of chronic lymphocytic leukemia treatment - Mayo Clinic
Lilly’s Jaypirca receives CHMP positive opinion for CLL in Europe - Pharmaceutical Technology
Atypical Cutaneous Manifestation Leading to the Diagnosis of Chronic Lymphocytic Leukemia - Cureus
Eli Lilly (LLY) Wins EMA Backing For Jaypirca In Chronic Lymphocytic Leukemia - Yahoo Finance
CHMP Recommends Pirtobrutinib for EU Approval in CLL Across All Lines of Therapy - OncLive
Treatment Considerations With Newly Diagnosed Older CLL Patients - Targeted Oncology
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia - Nature
Zanubrutinib vs Ibrutinib in TB CLL: Implications for Interpreting Fixed-Duration Treatment Outcomes from CLL17 - OncLive
Advice for Community Oncologists on Optimizing Frontline BTKi for CLL - Targeted Oncology
Real-World Impact of Atrial Fibrillation on Cardiovascular Outcomes and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukemia - OncLive
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval - Pharmaceutical Executive
Significant New Treatment Options Emerge for Patients With CLL - Hematology Advisor
Small Lymphocytic Lymphoma Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
Outcomes During BTKi Treatment for Chronic Lymphocytic Leukemia: Insights From Remote Therapeutic Monitoring - OncLive
A leukemia survivor’s perspective on aligning care with what matters most - UT MD Anderson
Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction - Nature
CLL14 Long-Term Follow-Up and IGHV-Guided Treatment Selection - OncLive
Multiple myeloma with concomitant chronic lymphocytic leukemia: evidence for independent clonal origin - Nature
In-silico identification of genetic variants associated with chronic lymphocytic leukemia for diagnostic and therapeutic applications - Nature
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights - Nature
Leukemia: What Primary Care Physicians Need to Know - American Academy Of Family Physicians | AAFP
People With Chronic Lymphocytic Leukemia May Not Need Continuous Treatment - Cancer Health
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study - Nature
Calquence plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukaemia in the 1st-line setting - AstraZeneca
First-line treatment for CLL in the era of targeted therapy - Blood Cancer Journal - Nature
Pirtobrutinib Combination “Potential New Standard-of-Care Option” in R/R CLL - Cancer Therapy Advisor
Chronic lymphocytic leukemia specificity analyses unveil bacterial lipopolysaccharides as the cognate ligands of established stereotyped BCR subsets | Blood Cancer Journal - Nature
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia - Wiley & Sons
How CLL Treatment Is Evolving: Targeted Therapy, Sequencing, and Treatment Selection - Medscape
Dueling Malignancies: A Rare Case of Concurrent Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML) in a Multimorbid Elderly Patient - Cureus
Monoclonal Immunotactoid Glomerulopathy Associated With Chronic Lymphocytic Leukemia: A Case Report - Cureus
Case Report: Simultaneous chronic lymphocytic leukemia and macrofocal multiple myeloma with extramedullary plasmacytoma - Frontiers
Alliance trial aims to improve outcomes for chronic lymphocytic leukemia - EurekAlert!
Pirtobrutinib vs Ibrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - The ASCO Post
Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib - Nature
Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive - Oncodaily
Identifying Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma: An Uncommon Case of Ocular Adnexal Lymphoma - Cureus
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split - PR Newswire
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca - Yahoo Finance
A Rare Case of Concurrent Chronic Lymphocytic Leukemia and Therapy-Unrelated Acute Myeloid Leukemia That Evolved From Myelodysplastic Neoplasm - Cureus
Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatment - News-Medical
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia - Pharmacy Times
EU panel backs extending Jaypirca use to more leukemia patients - Rare Cancer News
B‐Cell Chronic Lymphocytic Leukemia in a Cat - Mori - 2025 - Veterinary Clinical Pathology - Wiley Online Library
Hemorrhagic Ascites in Chronic Lymphocytic Leukemia With Immunoglobulin Heavy Chain Variable Region 3-21 (IGHV3-21) Usage: A Case Requiring Individualized Treatment - Cureus
Chronic Lymphocytic Leukemia Highlights From ASH 2025 - Medscape
Commentary: A call to donate blood amid a critical shortage — Tom Purcell - Jacksonville Journal-Courier
ASH 2025 | Congress coverage: Chronic lymphocytic leukemia and small lymphocytic lymphoma - Lymphoma Hub
My CLL Is in Remission, Now What? - WebMD
Accelerated chronic lymphocytic leukemia — expert opinion on diagnosis and management - Via Medica Journals
Acute Lymphoblastic Leukemia (ALL) - MSD Manuals
Curis opens 11 cancer trial sites as reverse split plan advances - Stock Titan
Understanding the role of toggle genes in chronic lymphocytic leukemia proliferation - Nature
Neutrophils unveiled in chronic lymphocytic leukemia - Frontiers
Recent Developments in Chronic Lymphocytic Leukemia - MedPage Today
Genomic fusion breakpoints for DNA-based measurable residual disease monitoring in pediatric acute lymphoblastic leukemia - Nature
Lilly’s Jaypirca receives positive EU regulatory opinion for CLL - Investing.com
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia - The New England Journal of Medicine
Treatment for chronic lymphocytic leukaemia may have long-term effects on the immune system - Karolinska Institutet
Dr Shadman on uMRD Rates With Sonrotoclax Plus Zanubrutinib in Frontline CLL/SLL - OncLive
Curis opens 11 sites for CLL study, shareholders approve stock split - Investing.com
Eli Lilly (LLY) Is Up 10.0% After EU CLL Nod And GLP-1 Access Win - Has The Bull Case Changed? - simplywall.st
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC) - Elsevier
Neutrophils unveiled in chronic lymphocytic leukemia - Frontiers
Curis (CRIS) Launches Phase 2 CLL Study and Plans Reverse Stock Split - GuruFocus
Uncommon Manifestations of Newly Diagnosed B-cell Chronic Lymphocytic Leukemia Prompting the Concurrent Diagnosis of Advanced Prostate Cancer: A Case Report - Cureus
Truxima Becomes First Interchangeable Rituximab Biosimilar - Businesskorea
Recognizing Signs of Autoimmune Disease in Patients With Chronic Lymphocytic Leukemia - Hematology Advisor
Exercise could ease symptoms for people with chronic lymphocytic leukaemia (CLL) – new study - The Conversation
Lisaftoclax Wins Chinese Approval in Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - OncLive
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease - The New England Journal of Medicine
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study - Medical Xpress
Update on the management of relapsed/refractory chronic lymphocytic leukemia - Nature
Chronic lymphocytic leukemia treatment algorithm 2022 - Nature
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia - The New England Journal of Medicine
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures - Wiley Online Library
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations - Nature
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update - Nature
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker - Nature
Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies - Haematologica
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features - Nature
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia - The New England Journal of Medicine
People with Chronic Lymphocytic Leukemia benefit from exercise yet lack personalized guidance - News-Medical
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia - The New England Journal of Medicine
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia - The New England Journal of Medicine
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019 | Blood Cancer Journal - Nature
Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? | Blood Cancer Journal - Nature
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia - The New England Journal of Medicine
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation - Nature
Concurrent Metastatic Clear Cell Renal Cell Carcinoma and Chronic Lymphocytic Leukemia Within the Same Lymph Node: A Case Report and Review of Dual Malignancy Management - Cureus
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia - The New England Journal of Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'lymphocytic leukemia'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
lymphocyitc leukemia,   lymphpcytic leukemia,   lymphocytic leukemi,   ymphocytic leukemia,   lymphocytic elukemia,   lymphocyticl eukemia,   lymphocytic leukemua,   lymphocytic leukemia,   lymphocyyic leukemia,   lymphcoytic leukemia,   lymphocytic leukwmia,   lymphocytiv leukemia,   lymphocytix leukemia,   lymphocytic leukemis,   lymmphocytic leukemia,   lympocytic leukemia,   lymphocyytic leukemia,   lymphocytic leukenia,   lympphocytic leukemia,   lymphoccytic leukemia,   lymphocytic leukemiaa,   lymphocytic luekemia,   lymphocytoc leukemia,   lymphocytic leukemai,   llymphocytic leukemia,   lymphocytic leukmeia,   lymphocytic leulemia,   lymphoocytic leukemia,   lymohocytic leukemia,   lymphocytic lukemia,   lymphocytic leeukemia,   lymphoxytic leukemia,   lymphhocytic leukemia,   lymphicytic leukemia,   lympohcytic leukemia,   lymphocyti leukemia,   lymphocytic leukemmia,   lymphocyic leukemia,   lymphocytic lleukemia,   lymphocytuc leukemia,   lympgocytic leukemia,   lymphocytic lwukemia,   lymphocytic leuukemia,   lymphocyticleukemia,   lymphoctic leukemia,   lymphocytic leykemia,   lymphocytic lekuemia,   lymphoctyic leukemia,   lymphocyttic leukemia,   lymphocytic leukeima,   lymphocytic leuekmia,   lymphocytic leukeia,   lyphocytic leukemia,   lymphocytic leukema,   lymphocytic leujemia,   lymphocytic keukemia,   lymphocytic leukkemia,   lymphovytic leukemia,   ylmphocytic leukemia,   ;ymphocytic leukemia,   lyymphocytic leukemia,   lumphocytic leukemia,   lymphocyric leukemia,   lymhpocytic leukemia,   ltmphocytic leukemia,   lymphoyctic leukemia,   lymphocutic leukemia,   lymphocytic lrukemia,   lymphocytic leukmia,   lymphocytic ;eukemia,   kymphocytic leukemia,   lymphocytic leukemiia,   lymphocyticc leukemia,   lmyphocytic leukemia,   lymphoytic leukemia,   lypmhocytic leukemia,   lymphocytic lekemia,   lymphocytic eukemia,   lymphocytci leukemia,   lmphocytic leukemia,   lymphocytic leuke,ia,   lymphocttic leukemia,   lymphocytic leukrmia,   lymphocytic leikemia,   lym[hocytic leukemia,   lymphocyti cleukemia,   lymphocytic leukeemia,   lymhocytic leukemia,   lymphocytic leukemoa,   lynphocytic leukemia,   lympjocytic leukemia,   lymphocytic leuemia,   ly,phocytic leukemia,   lymphcytic leukemia,   lymphocytc leukemia,   lymphocytiic leukemia
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z